Analyst upgrades: TEVA, WFMI, CTAS, BCSI and AIG
Posted Jul 21st 2008 11:00AM by Eric Buscemi
Filed under: Analyst Upgrades and Downgrades, Cintas Corp (CTAS), Whole Foods Market (WFMI), Amer Intl Group (AIG), Teva Pharm Indus ADR (TEVA)
.gif)
MOST NOTEWORTHY: Teva Pharmaceutical, Blue Coat Systems and American International Group were today's noteworthy upgrades:
- Deutsche Bank upgraded shares of Teva Pharmaceutical (NASDAQ: TEVA) to Buy from Hold to reflect the company's greater growth prospects following the acquisition of Barr (NYSE: BRL). The firm raised the target to $56 from $47.
- ThinkPanmure upgraded Blue Coat Systems (NASDAQ: BCSI) to Buy from Source of Funds based on the company's growth prospects following positive channel checks.
- American International Group (NYSE: AIG) was raised to Buy from Neutral at Banc of America on valuation, as they find the risk/reward attractive at current levels.
OTHER UPGRADES:
- Goldman upgraded the Semiconductor Production Equipment sector to Neutral from Cautious and added Verigy (NASDAQ: VRGY) to its Conviction Buy List.
- Morgan Stanley upgraded Whole Foods (NASDAQ: WFMI) and Cintas (NASDAQ: CTAS) to Equal Weight from Underweight.
- Gibraltar Industries (NASDAQ: ROCK) was raised to Buy from Neutral at Piper.
Tags: aig, bcsi, brl, ctas, inthenews, rock, teva, vrgy, wfmi
5-Hour Energy: A Success Equal Parts Caffeine, Chemistry and…
Suddenly, Amazon Doesn't Love Its Moms Anymore
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
